PDB1J1E; Takeda S, Yamashita A, Maeda K, and Maeda Y (2003). "Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form". Nature424 (6944): 35–41. PMID12840750. doi:10.1038/nature01780.; rendered with PyMOL
Robertson I, Sun YB, MX Li, BD Sykes (2010). "A structural and functional perspective into the mechanism of Ca2+-sensitizers that target the cardiac troponin complex". Journal of Molecular and Cellular Cardiology49: 1031–1041. PMID20801130. doi:10.1016/j.yjmcc.2010.08.019.
Willott RH, Gomes AV, Chang AN, Parvatiyar MS, Pinto JR, Potter JD (May 2010). "Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?". J. Mol. Cell. Cardiol.48 (5): 882–92. PMID19914256. doi:10.1016/j.yjmcc.2009.10.031.
Antman EM, Tanasijevic MJ, Thompson B; et al. (October 1996). "Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes". N. Engl. J. Med.335 (18): 1342–9. PMID8857017. doi:10.1056/NEJM199610313351802.
Amsterdam, E. A.; Wenger, N. K.; Brindis, R. G.; Casey, D. E.; Ganiats, T. G.; Holmes, D. R.; Jaffe, A. S.; Jneid, H.; Kelly, R. F.; Kontos, M. C.; Levine, G. N.; Liebson, P. R.; Mukherjee, D.; Peterson, E. D.; Sabatine, M. S.; Smalling, R. W.; Zieman, S. J. (23 September 2014). "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000134.
Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD (January 2006). "Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning". JAMA295 (4): 398–402. PMID16434630. doi:10.1001/jama.295.4.398.
Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD (May 2005). "Cardiovascular manifestations of moderate to severe carbon monoxide poisoning". J. Am. Coll. Cardiol.45 (9): 1513–6. PMID15862427. doi:10.1016/j.jacc.2005.01.044.
Gaze DC,Collinson PO; Collinson, PO (December 2005). "Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardioprotection.". Expert Opin Drug Metab Toxicol.1 (4): 715–25. PMID16863435. doi:10.1517/17425255.1.4.715.
Bonnefoy E, Godon P, Kirkorian G, Chabaud S, Touboul P (April 2005). "Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta". Acta Cardiol60 (2): 165–70. PMID15887472. doi:10.2143/AC.60.2.2005027.
Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A (November 2005). "Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis". Circulation112 (20): 3088–96. PMID16286604. doi:10.1161/CIRCULATIONAHA.105.560128.
Urhausen A, Scharhag J, Herrmann M, Kindermann W (September 2004). "Clinical significance of increased cardiac troponins T and I in participants of ultra-endurance events". Am. J. Cardiol.94 (5): 696–8. PMID15342317. doi:10.1016/j.amjcard.2004.05.050.
Kobayashi S, Tanaka M, Tamura N, Hashimoto H, Hirose S (September 1992). "Serum cardiac troponin T in polymyositis/dermatomyositis". Lancet340 (8821): 726. PMID1355820. doi:10.1016/0140-6736(92)92262-E.
Zethelius B, Johnston N, Venge P (February 2006). "Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study". Circulation113 (8): 1071–8. PMID16490824. doi:10.1161/CIRCULATIONAHA.105.570762.
PDB1J1E; Takeda S, Yamashita A, Maeda K, and Maeda Y (2003). "Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form". Nature424 (6944): 35–41. PMID12840750. doi:10.1038/nature01780.; rendered with PyMOL
Robertson I, Sun YB, MX Li, BD Sykes (2010). "A structural and functional perspective into the mechanism of Ca2+-sensitizers that target the cardiac troponin complex". Journal of Molecular and Cellular Cardiology49: 1031–1041. PMID20801130. doi:10.1016/j.yjmcc.2010.08.019.
Willott RH, Gomes AV, Chang AN, Parvatiyar MS, Pinto JR, Potter JD (May 2010). "Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?". J. Mol. Cell. Cardiol.48 (5): 882–92. PMID19914256. doi:10.1016/j.yjmcc.2009.10.031.
Antman EM, Tanasijevic MJ, Thompson B; et al. (October 1996). "Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes". N. Engl. J. Med.335 (18): 1342–9. PMID8857017. doi:10.1056/NEJM199610313351802.
Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD (January 2006). "Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning". JAMA295 (4): 398–402. PMID16434630. doi:10.1001/jama.295.4.398.
Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD (May 2005). "Cardiovascular manifestations of moderate to severe carbon monoxide poisoning". J. Am. Coll. Cardiol.45 (9): 1513–6. PMID15862427. doi:10.1016/j.jacc.2005.01.044.
Gaze DC,Collinson PO; Collinson, PO (December 2005). "Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardioprotection.". Expert Opin Drug Metab Toxicol.1 (4): 715–25. PMID16863435. doi:10.1517/17425255.1.4.715.
Bonnefoy E, Godon P, Kirkorian G, Chabaud S, Touboul P (April 2005). "Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta". Acta Cardiol60 (2): 165–70. PMID15887472. doi:10.2143/AC.60.2.2005027.
Needham DM, Shufelt KA, Tomlinson G, Scholey JW, Newton GE (October 2004). "Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature". Can J Cardiol20 (12): 1212–8. PMID15494773.
Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A (November 2005). "Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis". Circulation112 (20): 3088–96. PMID16286604. doi:10.1161/CIRCULATIONAHA.105.560128.
Urhausen A, Scharhag J, Herrmann M, Kindermann W (September 2004). "Clinical significance of increased cardiac troponins T and I in participants of ultra-endurance events". Am. J. Cardiol.94 (5): 696–8. PMID15342317. doi:10.1016/j.amjcard.2004.05.050.
Kobayashi S, Tanaka M, Tamura N, Hashimoto H, Hirose S (September 1992). "Serum cardiac troponin T in polymyositis/dermatomyositis". Lancet340 (8821): 726. PMID1355820. doi:10.1016/0140-6736(92)92262-E.
Zethelius B, Johnston N, Venge P (February 2006). "Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study". Circulation113 (8): 1071–8. PMID16490824. doi:10.1161/CIRCULATIONAHA.105.570762.
PDB1J1E; Takeda S, Yamashita A, Maeda K, and Maeda Y (2003). "Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form". Nature424 (6944): 35–41. PMID12840750. doi:10.1038/nature01780.; rendered with PyMOL
sourceforge.net
pymol.sourceforge.net
PDB1J1E; Takeda S, Yamashita A, Maeda K, and Maeda Y (2003). "Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form". Nature424 (6944): 35–41. PMID12840750. doi:10.1038/nature01780.; rendered with PyMOL